Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US

More Jobs >>

Events

CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA
Partnerships in Clinical Trials 2012
March 4-7 — Orlando, FL

More Events >>

Related Tags >> Vaccine FDA Barr Pharmaceuticals adenovirus

BLA News

Most Popular BLA Story

FDA accepts Barr BLA for first biologics

December 11, 2008 — 5:28pm ET | By Calisha Myers

Barr Pharmaceuticals announced Thursday that the FDA has accepted their application for the company's first two biologics, developed for the Department of Defense. The vaccine pills are designed to Read more...

BLA Press Releases

Santarus and Pharming Announce Receipt of FDA Refusal to File Letter for RHUCIN Biologics License Application
Research and Markets: Teva Pharmaceutical Industries Generics Company Intelligence Report 2011
Bioartificial Human Liver Therapy Trial Progressing
XIAFLEX for the Treatment of Dupuytren's Contracture Receives Priority Review From the U.S. Food and Drug Administration
FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab

Latest Headlines

FDA accepts Barr BLA for first biologics
December 11, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK